HomeAI · summaries
Storia in 3 fonti
Trump touts drug pricing pact with Regeneron aimed at lowering costs
Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump administration.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
axios.com
Trump cuts drug price deal with Regeneron
Regeneron is the last of 17 companies the administration pressed to commit to the "most favored nation" policy.
- ·
cnbc.com
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.
